Kathmandu. Om Megashree Pharmaceuticals Limited has called for a special general meeting. The company has called a special general meeting to acquire Royal Pharmaceuticals Pvt. Ltd.

The agenda of the AGM is to approve the report presented by the Board of Directors and endorse the decisions taken so far during the acquisition process, correspondence, procedures with the regulators and other necessary actions.

Similarly, a proposal to approve share swap ratio determined on the basis of due diligence audit (DDA) report, property and liability valuation report and recommendations of independent valuers will also be presented in the meeting.

The AGM will approve the final memorandum of understanding relating to the acquisition of Royal Pharmaceuticals Pvt. Ltd., the acquisition plan, business plan and other necessary documents. Similarly, a proposal to issue and allocate shares of Om Megashree Pharmaceuticals to the shareholders of Royal Pharmaceuticals as per the approved share swap ratio will also be approved.

A proposal regarding amendments required in the Company’s authority, issued and paid-up capital, share structure, Memorandum of Association and Articles of Association will also be presented in the AGM due to the acquisition process.

In addition, the proposal proposes to give full authority to the Board of Directors to make necessary amendments and implement the Companies Act, directives and approvals from the Securities Board of Nepal, Nepal Stock Exchange (NEPSE), CDSC and Clearing Limited, Office of the Company Registrar, Department of Industry and other regulatory bodies.

The company will close the book for the special general meeting (SGM) on July 22. Only the shareholders who have been transacted in NEPSE till that date and are in the shareholders’ register of the company are eligible to participate in the AGM.